Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes

Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes Publisher Pubmed

Fathollahi A¹ ; Massoud A¹ ; Amirzargar AA^{1, 2} ; Aghili B¹ ; Nasli Esfahani E^{3, 4} ; Rezaei N^{1, 5, 6}

Show Affiliations

1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran
5. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
6. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Boston, MA, United States

Source: Fetal and Pediatric Pathology Published:2018

Abstract

Background/Objective: This study was performed to compare soluble levels of adhesion molecules between diabetic patients and controls and to assess their possible association with long-term complications of type 1 diabetes (T1D). Methods: Forty-eight patients with T1D and 39 healthy controls were enrolled in this study. The plasma level of adhesion molecules was measured by sandwich enzyme-linked immunosorbent assay technique. Results: Higher sVCAM 1 (soluble vascular cell adhesion molecule 1) levels correlated with older age of onset of T1D. The plasma level of sICAM 1 (soluble intercellular adhesion molecule 1) was significantly increased, while sE selectin was significantly decreased in patients with T1D, compared to controls. There was no significant relationship between these plasma-level variations and the long-term complications of T1D. Conclusion: Although plasma levels of cell adhesion molecules are different in T1D patients and healthy controls, they might not be good candidate markers for prognosis of disease. © 2018 Taylor & Francis Group, LLC.

Related Docs

1. Superparamagnetic Iron Oxide Nanoparticles for in Vivo Molecular and Cellular Imaging, Contrast Media and Molecular Imaging (2015)

Experts (# of related papers)

Fatemeh Atyabi (1)

Style	Citing Format
MLA	Fathollahi A, et al.. "Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes." Fetal and Pediatric Pathology, vol. 37, no. 1, 2018, pp. 69-73.
APA	Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli Esfahani E, Rezaei N (2018). Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes. Fetal and Pediatric Pathology, 37(1), 69-73.
Chicago	Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli Esfahani E, Rezaei N. "Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes." Fetal and Pediatric Pathology 37, no. 1 (2018): 69-73.
Harvard	Fathollahi A et al. (2018) 'Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes', Fetal and Pediatric Pathology, 37(1), pp. 69-73.
Vancouver	Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli Esfahani E, Rezaei N. Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes. Fetal and Pediatric Pathology. 2018;37(1):69-73.
BibTex	@article{ author = {Fathollahi A and Massoud A and Amirzargar AA and Aghili B and Nasli Esfahani E and Rezaei N}, title = {Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes}, journal = {Fetal and Pediatric Pathology}, volume = {37}, number = {1}, pages = {69-73}, year = {2018} }
RIS	TY - JOUR AU - Fathollahi A AU - Massoud A AU - Amirzargar AA AU - Aghili B AU - Nasli Esfahani E AU - Rezaei N TI - Sicam-1, Svcam-1 and Se-Selectin Levels in Type 1 Diabetes JO - Fetal and Pediatric Pathology VL - 37 IS - 1 SP - 69 EP - 73 PY - 2018 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract